Browsing Category

64859 posts
AV-Comparatives Names Consumer Product of The Year in Summary Report 2023

AV-Comparatives Names Consumer Product of The Year in Summary Report 2023

INNSBRUCK, Austria, Jan. 29, 2024 /PRNewswire/ — AV-Comparatives awards Kaspersky as Product…
Lion's OTC Options Services Grows Significantly, Unlocking New Territory for Its Brokerage Business

Lion's OTC Options Services Grows Significantly, Unlocking New Territory for Its Brokerage Business

HONG KONG, Jan. 29, 2024 /PRNewswire/ — Lion Group Holding Ltd. ("Lion" or…
Vesicure Therapeutics made notable advancements using exosomes to target KRAS mutation

Vesicure Therapeutics made notable advancements using exosomes to target KRAS mutation

SUZHOU, China, Jan. 29, 2024 /PRNewswire/ — SiRNA technology offers distinct advantages over…
JETOUR T2 Debuts in the UAE, Featuring Advanced XWD Technology

JETOUR T2 Debuts in the UAE, Featuring Advanced XWD Technology

DUBAI, UAE, Jan. 29, 2024 /PRNewswire/ — On January 27th, 2024, JETOUR…
Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy Utilizing the Company's Proprietary Platform, for the Treatment of Relapsed/Refractory Multiple Myeloma.

Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy Utilizing the Company's Proprietary Platform, for the Treatment of Relapsed/Refractory Multiple Myeloma.

SHANGHAI and ROSELAND, N.J., Jan. 29, 2024 /PRNewswire/ — Oricell Therapeutics (Oricell),…
Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial

Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial

SUZHOU, China, Jan. 29, 2024 /PRNewswire/ — Peijia Medical Limited (Peijia, (9996.HK)),…
Ractigen Therapeutics Enters Strategic Partnership with University Medical Center Utrecht to Drive saRNA Innovation in Neurodevelopmental Disorders

Ractigen Therapeutics Enters Strategic Partnership with University Medical Center Utrecht to Drive saRNA Innovation in Neurodevelopmental Disorders

SUZHOU, China, Jan. 29, 2024 /PRNewswire/ — Ractigen Therapeutics, a clinical-stage pharmaceutical…
Dingdong Announces US.0 Million Share Repurchase Program

Dingdong Announces US$20.0 Million Share Repurchase Program

SHANGHAI, Jan. 29, 2024 /PRNewswire/ — Dingdong (Cayman) Limited ("Dingdong" or the…